Thiruganasambandamoorthy Venkatesh, Kwong Kenneth, Wells George A, Sivilotti Marco L A, Mukarram Muhammad, Rowe Brian H, Lang Eddy, Perry Jeffrey J, Sheldon Robert, Stiell Ian G, Taljaard Monica
Departments of Emergency Medicine (Thiruganasambandamoorthy, Perry, Stiell) and of Epidemiology and Community Medicine (Thiruganasambandamoorthy, Kwong, Wells, Perry, Stiell, Taljaard), University of Ottawa; Ottawa Hospital Research Institute (Thiruganasambandamoorthy, Kwong, Mukarram, Perry, Stiell, Taljaard), The Ottawa Hospital, Ottawa, Ont.; Departments of Emergency Medicine (Sivilotti) and of Biomedical and Molecular Sciences (Sivilotti), Queen's University, Kingston, Ont.; Department of Emergency Medicine and School of Public Health (Rowe), University of Alberta, Edmonton, Alta.; Departments of Emergency Medicine (Lang) and Medicine (Sheldon), University of Calgary, Calgary, Alta.
CMAJ. 2016 Sep 6;188(12):E289-E298. doi: 10.1503/cmaj.151469. Epub 2016 Jul 4.
Syncope can be caused by serious conditions not evident during initial evaluation, which can lead to serious adverse events, including death, after disposition from the emergency department. We sought to develop a clinical decision tool to identify adult patients with syncope who are at risk of a serious adverse event within 30 days after disposition from the emergency department.
We prospectively enrolled adults (age ≥ 16 yr) with syncope who presented within 24 hours after the event to 1 of 6 large emergency departments from Sept. 29, 2010, to Feb. 27, 2014. We collected standardized variables at index presentation from clinical evaluation and investigations. Adjudicated serious adverse events included death, myocardial infarction, arrhythmia, structural heart disease, pulmonary embolism, serious hemorrhage and procedural interventions within 30 days.
We enrolled 4030 patients with syncope; the mean age was 53.6 years, 55.5% were women, and 9.5% were admitted to hospital. Serious adverse events occurred in 147 (3.6%) of the patients within 30 days after disposition from the emergency department. Of 43 candidate predictors examined, we included 9 in the final model: predisposition to vasovagal syncope, heart disease, any systolic pressure reading in the emergency department < 90 or > 180 mm Hg, troponin level above 99th percentile for the normal population, abnormal QRS axis (< -30° or > 100°), QRS duration longer than 130 ms, QTc interval longer than 480 ms, emergency department diagnosis of cardiac syncope and emergency department diagnosis of vasovagal syncope (C statistic 0.88, 95% confidence interval [CI] 0.85-0.90; optimism 0.015; goodness-of-fit p = 0.11). The risk of a serious adverse event within 30 days ranged from 0.4% for a score of -3 to 83.6% for a score of 11. The sensitivity was 99.2% (95% CI 95.9%-100%) for a threshold score of -2 or higher and 97.7% (95% CI 93.5%-99.5%) for a threshold score of -1 or higher.
The Canadian Syncope Risk Score showed good discrimination and calibration for 30-day risk of serious adverse events after disposition from the emergency department. Once validated, the tool will be able to accurately stratify the risk of serious adverse events among patients presenting with syncope, including those at low risk who can be discharged home quickly.
晕厥可能由初始评估时未发现的严重疾病引起,这可能导致在从急诊科转出后发生严重不良事件,包括死亡。我们试图开发一种临床决策工具,以识别在从急诊科转出后30天内有发生严重不良事件风险的成年晕厥患者。
我们前瞻性纳入了2010年9月29日至2014年2月27日期间在事件发生后24小时内到6家大型急诊科之一就诊的成年(年龄≥16岁)晕厥患者。我们在初次就诊时从临床评估和检查中收集标准化变量。判定的严重不良事件包括死亡、心肌梗死、心律失常、结构性心脏病、肺栓塞、严重出血以及30天内的程序性干预。
我们纳入了4030例晕厥患者;平均年龄为53.6岁,55.5%为女性,9.5%入院治疗。147例(3.6%)患者在从急诊科转出后30天内发生了严重不良事件。在检查的43个候选预测因素中,我们在最终模型中纳入了9个:血管迷走性晕厥倾向、心脏病、急诊科任何收缩压读数<90或>180 mmHg、肌钙蛋白水平高于正常人群第99百分位数、异常QRS轴(<-30°或>100°)、QRS时限长于130 ms、QTc间期长于480 ms、急诊科心脏性晕厥诊断和急诊科血管迷走性晕厥诊断(C统计量0.88,95%置信区间[CI]0.85 - 0.90;乐观度0.015;拟合优度p = 0.11)。30天内发生严重不良事件的风险范围为:评分为-3时为0.4%,评分为11时为83.6%。阈值评分为-2或更高时敏感性为99.2%(95%CI 95.9% - 100%),阈值评分为-1或更高时敏感性为97.7%(95%CI 93.5% - 99.5%)。
加拿大晕厥风险评分对急诊科转出后30天严重不良事件风险具有良好的区分度和校准度。一旦得到验证,该工具将能够准确分层晕厥患者发生严重不良事件的风险,包括那些低风险可快速出院回家的患者。